Maravai LifeSciences Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on Maravai LifeSciences Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Maravai LifeSciences Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Maravai LifeSciences Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Maravai LifeSciences Holdings Inc (Maravai LifeSciences) is a life sciences company that focuses on supporting biotech, biopharma, and life sciences companies in developing vaccines, therapeutics, and diagnostics. The company's products include nuclear acid products such as RNA capping, mRNA raw materials, custom oligonucleotides, custom nucleic acid synthesis, oligonucleotide synthesis inputs, and specialty enzymes; and biologics safety testing products such as host cell protein detection kits and viral contamination kits. The company's brands include CleanCap, TriLink BioTechnologies, Cygnus Technologies, CleanAmp, MockV, and Glen Pak. Maravai LifeSciences is headquartered in San Diego, California, the US.
Headquarters
United States of America
Address
10770 Wateridge Circle Suite 200, Suite 200, San Diego, California, 92121
Website
www.maravai.com
Telephone
1 858 5460004
No of Employees
416
Industry
Medical Equipment
Ticker Symbol & Exchange
MRVI (NASD)
Revenue (2024)
$185.7M
-28.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
9.7%
(2024 vs 2023)
Market Cap*
$1.7B
Net Profit Margin (2024)
XYZ
-26.0%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products | Brands |
|---|---|
| Reagents | CleanCap |
| Critical Products | TriLink BioTechnologies |
| Nuclear Acid Production: | CleanAmp |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Acquisitions/Mergers/Takeovers | In January, the company acquired intellectual property and relevant assets from Molecular Assemblies. |
| 2024 | Contracts/Agreements | In October, Alphazyme LLC entered into an agreement with Codexis, Inc. for multiple enzymes in Codexis’ life science enzyme portfolio. |
| 2024 | Contracts/Agreements | In September, the company's subsidiaries, TriLink BioTechnologies and Alphazyme entered into a partnership to introduce CleanScribe RNA Polymerase. |
Competitor Comparison
| Key Parameters | Maravai LifeSciences Holdings Inc | Thermo Fisher Scientific Inc | Lonza Group Ltd | Catalent Inc | Samsung Biologics Co Ltd |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Switzerland | United States of America | South Korea |
| City | San Diego | Waltham | Basel | Somerset | Incheon |
| State/Province | California | Massachusetts | - | New Jersey | - |
| No. of Employees | 416 | 125,000 | 16,866 | 16,900 | 5,455 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Andrew Eckert | Chairman | Executive Board | 2024 | 64 |
| Bernd Brust | Chief Executive Officer; Director | Executive Board | 2025 | 59 |
| Rajesh Asarpota | Chief Financial Officer; Executive Vice President | Senior Management | 2025 | 59 |
| Chanfeng Zhao | Chief Scientific Officer; Senior Vice President | Senior Management | - | - |
| Kevin Lynch | Vice President; General Manager - CDMO Services | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer